These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33506442)

  • 1. A Netnography and a Survey on Doping Use among Competitive Doping-untested Strength-sport Athletes.
    Jokipalo I; Khudayarov A
    Int J Sports Med; 2021 Jun; 42(7):645-650. PubMed ID: 33506442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doping in sport: effects, harm and misconceptions.
    Birzniece V
    Intern Med J; 2015 Mar; 45(3):239-48. PubMed ID: 25369881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of athlete biological passport biomarkers and clinical parameters in male and female users of anabolic androgenic steroids and other doping agents.
    Börjesson A; Lehtihet M; Andersson A; Dahl ML; Vicente V; Ericsson M; Ekström L
    Drug Test Anal; 2020 Apr; 12(4):514-523. PubMed ID: 31925932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-reported attitudes of elite athletes towards doping: differences between type of sport.
    Alaranta A; Alaranta H; Holmila J; Palmu P; Pietilä K; Helenius I
    Int J Sports Med; 2006 Oct; 27(10):842-6. PubMed ID: 16586338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of testosterone and anabolic androgenic steroids in sport].
    Medraś M; Jóźków P
    Endokrynol Pol; 2009; 60(3):204-9. PubMed ID: 19569021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recreational athletes and doping--a survey in 11 gyms in the area of Frankfurt/Main].
    Raschka C; Chmiel C; Preiss R; Boos C
    MMW Fortschr Med; 2013 Jul; 155 Suppl 2():41-3. PubMed ID: 24930320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doping in sport and exercise: anabolic, ergogenic, health and clinical issues.
    Bird SR; Goebel C; Burke LM; Greaves RF
    Ann Clin Biochem; 2016 Mar; 53(Pt 2):196-221. PubMed ID: 26384361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An (un)desirable trade of harms? How elite athletes might react to medically supervised 'doping' and their considerations of side-effects in this situation.
    Overbye M
    Int J Drug Policy; 2018 May; 55():14-30. PubMed ID: 29477956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doping Prevalence in Competitive Sport: Evidence Synthesis with "Best Practice" Recommendations and Reporting Guidelines from the WADA Working Group on Doping Prevalence.
    Gleaves J; Petróczi A; Folkerts D; de Hon O; Macedo E; Saugy M; Cruyff M
    Sports Med; 2021 Sep; 51(9):1909-1934. PubMed ID: 33900578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Doctors belonging to the Senegalese Association of Sport Medicine and doping in sports: survey on knowledge and attitudes].
    Dièye AM; Diallo B; Fall A; Ndiaye M; Cissè F; Faye B
    Sante; 2005; 15(3):167-70. PubMed ID: 16207578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Growth hormone and IGF-1 as doping agents in competitive sport].
    Jóźków P; Medraś M
    Endokrynol Pol; 2009; 60(5):389-94. PubMed ID: 19885810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies that athletes use to avoid detection of androgenic-anabolic steroid doping and sanctions.
    Alquraini H; Auchus RJ
    Mol Cell Endocrinol; 2018 Mar; 464():28-33. PubMed ID: 28130115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Athletes using ergogenic and medical sport supplements report more favourable attitudes to doping than non-users.
    Hurst P; Ring C; Kavussanu M
    J Sci Med Sport; 2021 Mar; 24(3):307-311. PubMed ID: 32998850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative description of the prevalence and use of anabolic androgenic steroids by United States powerlifters.
    Curry LA; Wagman DF
    Percept Mot Skills; 1999 Feb; 88(1):224-33. PubMed ID: 10214647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of anabolic-androgenic steroids by Canadian students.
    Melia P; Pipe A; Greenberg L
    Clin J Sport Med; 1996 Jan; 6(1):9-14. PubMed ID: 8925377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of anabolic steroid use and associated factors among body-builders in Hamadan, West province of Iran.
    Razavi Z; Moeini B; Shafiei Y; Bazmamoun H
    J Res Health Sci; 2014; 14(2):163-6. PubMed ID: 24728754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychological and social correlates of doping attitudes among Italian athletes.
    Zucchetti G; Candela F; Villosio C
    Int J Drug Policy; 2015 Feb; 26(2):162-8. PubMed ID: 25168080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anabolic-Androgenic Steroid Use in Sports, Health, and Society.
    Bhasin S; Hatfield DL; Hoffman JR; Kraemer WJ; Labotz M; Phillips SM; Ratamess NA
    Med Sci Sports Exerc; 2021 Aug; 53(8):1778-1794. PubMed ID: 34261998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis.
    Christou MA; Christou PA; Markozannes G; Tsatsoulis A; Mastorakos G; Tigas S
    Sports Med; 2017 Sep; 47(9):1869-1883. PubMed ID: 28258581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.